Applied Stem Cell, Inc. Strengthens Executive Leadership With Two Key Appointments
Dec 04, 2023•over 1 year ago
Position
Chief Commercial Officer
Company
Applied StemCell
Description
Applied StemCell Inc, a leading CRO/CDMO recognized for its proprietary TARGATT gene editing technology and expertise in stem cells and cell therapy development, is pleased to announce the addition of two accomplished professionals to its C-level executive team: George Hong (Chief Commercial Officer) and Timothy J. Largen (Chief Operating Officer)
FundzWatch™ Score
89
Medium Activity
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months